Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid Tumors

Clinical trial NCT05586321 · COMPLETED

Trial details

NCT number: NCT05586321
Sponsor: Genmab
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2022-10-24
Primary completion: 2025-10-23
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.